Phase II study of oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1–associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase II study of oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1–associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-04-01
DOI
10.1093/neuonc/noaa071
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial
- (2019) Jason Fangusaro et al. LANCET ONCOLOGY
- Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
- (2019) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- A multi-institutional study of brainstem gliomas in children with neurofibromatosis type 1
- (2017) Jasia Mahdi et al. NEUROLOGY
- Neurofibromatosis type 1 associated low grade gliomas: A comparison with sporadic low grade gliomas
- (2016) Jelte Helfferich et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study
- (2016) Alvaro Lassaletta et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study
- (2016) David N. Franz et al. PLoS One
- Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multiagent chemotherapy
- (2015) Andrew J. Dodgshun et al. INTERNATIONAL JOURNAL OF CANCER
- Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: An analysis of the Surveillance Epidemiology and End Results (SEER) database
- (2014) Pratiti Bandopadhayay et al. PEDIATRIC BLOOD & CANCER
- NF1gene silencing induces upregulation of vascular endothelial growth factor expression in both Schwann and non-Schwann cells
- (2013) Yasuhiro Kawachi et al. EXPERIMENTAL DERMATOLOGY
- A multi-disciplinary consensus statement concerning surgical approaches to low-grade, high-grade astrocytomas and diffuse intrinsic pontine gliomas in childhood (CPN Paris 2011) using the Delphi method
- (2013) D. A. Walker et al. NEURO-ONCOLOGY
- Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas—a Pediatric Brain Tumor Consortium study
- (2013) Sridharan Gururangan et al. NEURO-ONCOLOGY
- A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer
- (2013) Nathan J. Robison et al. PEDIATRIC BLOOD & CANCER
- Phase II Study of Weekly Vinblastine in Recurrent or Refractory Pediatric Low-Grade Glioma
- (2012) Eric Bouffet et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group
- (2012) Joann L. Ater et al. JOURNAL OF CLINICAL ONCOLOGY
- Natural history and management of low-grade glioma in NF-1 children
- (2010) Pablo Hernáiz Driever et al. JOURNAL OF NEURO-ONCOLOGY
- Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis
- (2010) Darcy A. Krueger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preclinical Cancer Therapy in a Mouse Model of Neurofibromatosis-1 Optic Glioma
- (2008) B. Hegedus et al. CANCER RESEARCH
- Dose- and Schedule-Dependent Inhibition of the Mammalian Target of Rapamycin Pathway With Everolimus: A Phase I Tumor Pharmacodynamic Study in Patients With Advanced Solid Tumors
- (2008) Josep Tabernero et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanism-Based Concepts of Size and Maturity in Pharmacokinetics
- (2007) B.J. Anderson et al. Annual Review of Pharmacology and Toxicology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started